VCCircle

Abhay is a Managing Director with Sequoia Capital India. Prior to joining Sequoia Capital, Abhay was head of Real Estate and Infrastructure investment banking at DSP Merrill Lynch where he led capital raising for the largest Indian companies in these sectors including the largest Indian initial public offering for DLF Ltd. Prior to that, Abhay worked at McKinsey & Co, in Mumbai and Johannesburg. At McKinsey, Abhay worked with a number of leading Indian corporations in the Media and Entertainment and Manufacturing sectors. Abhay received an MBA from IIM Calcutta and a B. Tech. in Computer Science and Engineering from IIT Bombay.

Amit is a Partner with KPMG’s strategy, M&A and Private Equity advisory practice.  He leads the Healthcare vertical for KPMG in India.

During his career he has worked with organizations like Arthur Andersen and Infosys before joining KPMG across India and the USA. Amit has led more than 100 engagements during his career with Indian and multinational corporations, funding organizations like the World Bank and DFID, Governments, Private Equity and Venture funds and startups.

He has worked across industry sectors including Healthcare, Education, Financial Services, Real Estate, Utilities, Transportation, Food and Beverages, IT/ITES, Textiles, Engineering, FMCG and Pharmaceuticals. 

Amit is a Bachelor of Economics from University of Kolkata and a MBA from FMS, Delhi.

Dr. Amit Sachdeva, is a Co- Promoter of Axiss Dental. He is an Orthodontist by qualification, but his journey till date has been associated with working as Dentist in his early phase of life, followed by forming and promoting Axiss Dental chain of clinics as part of various hospital based setup associated with large corporate hospital like Fortis , Apollo, Columbia Asia. Now in the recent time post funding, he is leading the management of  Axiss Dental towards an organic Retail based growth path by establishing Axiss Dental as the leading Dental Service brand  across Pan India. His focus has always been on a establishing health care practice as a more process driven enterprise, so that the patient gets the best of the skill and service.

Dr Amit Varma currently operates as President Health Care, Religare Enterprises and Director, Critical Care Medicine, Fortis Escorts group of Hospitals, India. Having completed his MBBS and MD from University of Delhi, Dr Varma further completed his residency from the State University of New York. Thereafter he went on to pursue fellowships in critical care at the University of Pittsburgh Medical Center, and sub specialized in cardiac critical care at the Cleveland Clinic. Alongside this, he also attended courses for an Executive MBA at the University of Chicago.

After almost a decade in USA, Dr Varma began his professional journey in India at the Manipal Heart Foundation in Bangalore. He subsequently moved on to the Narayan Hrudayalaya Hospital as the consultant- in-charge of Critical Care. Early in 2003, Dr Varma joined Fortis Healthcare, where he has and continues to perform multiple administrative and clinical roles. He currently runs the integrated critical care services for Fortis Healthcare ICU network, which today comprises of a strong three-Hundred beds and helps in ormulation of Medical Strategy.

At Religare from 2009, Dr Varma is actively engaged in all healthcare initiatives of the company, playing an advisory and steering role, overlooking and further initiating all healthcare related businesses, providing medical expertise, insight and credibility in all healthcare related verticals such as Health Insurance venture, Healthcare IT, Super Religare Labs and Religare Wellness. He also sits on the Board and Investment committee of the 125$ million Milestone Religare Private Equity fund which is investing domestically in the healthcare and education fields.

Ben joined NEA in 2006 to focus on investments in the rapidly growing Indian markets. In January 2007, he launched New Enterprise Associates (India) Pvt. Ltd. and opened its Bangalore office. He is currently on the board of ValueFirst, Nova Medical Centers, NephroLife, InTarvo and Novatium and works closely with Intellisys, Deeya Energy and NEA's other India related investments.

Prior to joining NEA, Ben held senior positions at E2open (NASDAQ: EOPN) and  i2 Technologies (acquired by JDA Software). Previously, Ben spent a few years at PwC Consulting (acquired by IBM) as a part of the retail consulting practice. In his early career, he was at Open Environment Corporation and built application development tools for Distributed Computing. Ben received his Master of Science in Engineering Sciences from Dartmouth College and his Bachelor of Technology from the Indian Institute of Technology, Madras.

Thyrocare, the worlds largest Thyroid testing laboratory was founded in the year 1996 by Dr A Velumani, an ex Scientist from BARC. Schooled at a small village, Appanaickenpatti (coimbatore, TN), his pathology laboratory has been registering an Year over Year growth of 100% for more than 10 years.

Thyrocare which was started in a 150 sq feet garage, with an investment of Rs.1,00,000 today stands at a 50,000 sq feet office in Navimumbai and does daily more than 50,000 tests with a capability of processing about five lakh investigations per day. The company specialises in immunodiagnostics, testing blood samples for thyroid disorders.

Dr. G.S.K Velu who has over 18 years of experience in the diagnostics and healthcare industry, and has worked in several multinational companies such as Ciba Corn Diagnostics, Chevron Diagnostics etc., in the capacity of Director (South Asia). He completed his graduation in Pharmaceutical Engineering from BITS Pilani and Post Graduated in Business Administration from Loyala Institute of Administration (LIBA) Chennai and Ph.D in Pharmacology from Indian Board of Alternative Medicines, Calcutta. He is also in the honorary faculty of Sri Ramachandra Hospital and Research Institute (Deemed) University.  He is also in the Board of Several Diagnostics and Medical Devices Companies in India and elsewhere.  He is the Founder and Managing Director of one of the most successful medical device and diagnostics company, Trivitron.  He contributes with his expertise in corporate marketing and diagnostic sales. He has been awarded the Entrepreneur of the year 2006 by Modern Medicare Magazine  which is a leading healthcare magazine.

While working in some of UK's top medical institutions, witnessing the hardships of Liver transplant patients and their painstaking ordeal, spending huge amounts of money, Dr. Kancherla Ravindranath realized the urgent need for a Liver transplant facility in India.

Deeply touched by the plight of hundreds of patients' and inspired by his late Father's advice to come back to serve India, Dr. Ravindranath relinquished his very successful practice in UK and returned to India to establish Global Hospitals.

Dr. Kancherla Ravindranath, is a world-renowned expert in Surgical Gastroenterology, and the founder of Global Hospitals Group acknowledged as India's fastest growing chain of tertiary care multi super specialty hospitals. Under Dr. Ravindranath's visionary leadership and guidance, Global Hospitals Group has become the premier and niche healthcare center that is in to performing high-end surgeries, such as the first ever liver, heart, twin kidney and bone marrow transplants in Andhra Pradesh and multiple such cutting edge and pioneering surgeries in India. Currently, with eight world class tertiary care Hospitals in Chennai, Bengaluru & Hyderabad, and soon Mumbai centre opening up, today Global Hospitals has grown to be acknowledged as the world's most comprehensive centre for Liver & Pancreas Diseases and Transplantation.

Manish has over 15 years of Investment Banking and Corporate Advisory experience in India. He has advised corporates from across sectors including consumers, infrastructure, media, financial services, natural resources, metals, education etc. Apart from having wide relationships and deep sector knowledge he also has valuable experience of working across investment banking products including Private Equity advisory, Mergers & Acquisitions, Capital Markets, structuring, financial engineering and valuations. Manish was instrumental in setting up Mid Market investment banking practice at Kotak Mahindra Group and as head of the practice led many transactions. He brings deep expertise in proactive deal sourcing, structuring, valuation and negotiations. One of the critical skill sets which he adds to the team is strategizing exits with a view to maximize value since he has extensive experience on IPOs and strategic sale

He is a Chartered Accountant by qualification and was an All India rank holder from November 1995 batch. Before TVS Capital Manish has worked with SBI Capital Markets, Ernst & Young- Corporate Finance and with Kotak Investment Banking

Monika heads the corporate advisory division of Feedback Ventures. A management graduate from IIM-A (batch of 1998), she has been working in the healthcare sector for the last ten years and has helped leading providers, governments as well as PE players in the sector in shaping their strategy, undertaking due diligence of targets, improving performance of existing assets, operationalising projects and facilitating PPP in healthcare.

She brings an understanding of the emerging opportunities in healthcare delivery, the challenges faced by providers, alternate business models and issues in their implementation, expectations of private equity players keen on investing in the healthcare space, prevalent market practices, consumer healthcare buying behaviour etc.

She has worked with leading providers such as Max, Wockhardt, Fortis, Care Group, Artemis, Moolchand, Sterling, Kamineni, SDMH, Baxter, Star hospitals etc. She has also advised various Private Equity players including Advent International, Arcapita, India Equity Partners, Actis, IDFC, Asian Healthcare Fund etc.

15 years into Indian healthcare industry Worked with GE Healthcare, GE Capital – Healthcare Financial Services, for 10 years – was into healthcare technology, funding to healthcare set-ups.

Subsequently moved  as CEO of a multi-specialty hospital before joining RG Urology and Laparoscopy Hospitals, ( a pan India chain of 15 urology and laparoscopy hospitals) as President & COO.

Dr.N.Krishna Reddy, has graduated from Osmania Medical College in 1984 with honors. He completed his MD in Internal Medicine from the prestigious Postgraduate Institute of Medical Education & Research (PGIMER), Chandigarh in 1987. He did his fellowship in Cardiology leading to DM from GB Pant Hospital, Delhi University, New Delhi.

He worked at Nizam’s Institute of Medical Sciences, Hyderabad, and Mediciti Hospitals, Hyderabad, prior to establishing Care Hospitals. He has pioneered advanced imaging techniques and electrophysiology procedures in the state of Andhra Pradesh. His contribution to landmark original research includes studies on Percutaneous Valvotomy for Rheumatic Mitral Stenosis, Prosthetic Valve Thrombosis, Role of Sildenafil in Primary Pulmonary Hypertension etc.

He conducted epidemiological studies on cardiovascular risk factors. He has been acting as Principal Investigator and National Lead Investigator for various multinational drug and device trials. He established a dedicated department of Clinical Research at Care Hospitals. He was the key member of the team that developed and tested India’s first indigenous coronary stent, popularly known as Kalam-Raju Stent.

He co-founded the Care Hospitals in 1997, which has grown rapidly from 100-bed strength, single hospital, single specialty entity to more than 1500-bed strength, 12-hospitals, 6-states, and multispecialty within a short span of 10 years. He is currently Managing Director, Andhra Cardiology Associates (ACA), which has the largest team of 50 Cardiologists managing Cardiology services in various Care Hospitals; Director & CEO at Care Hospitals since 2006; Member, Board of Directors, Care Foundation. He co-founded Relisys Medical Devices and is currently its Chairman. Relisys Medical Devices has created a cost-effective  end-to-end technology platform for both Stents and Polymer-based Catheters.

Dr. Om Manchanda is the Chief Executive Officer of Dr Lal PathLabs, India’s largest medical diagnostics company. Popularly known as ‘Om’ among his friends, colleagues and close business associates, he has a diverse experience of 20 years across sales, marketing and general management functions in business sectors such as FMCG, agri-biotech products, consumer healthcare and medical diagnostics.

Before joining Dr Lal PathLabs in 2005, Manchanda led the International & Innovation group of the Consumer Healthcare Division at Ranbaxy. He was part of the senior management team responsible for launching Ranbaxy’s foray into consumer healthcare.

Prior to Ranbaxy, he worked for Monsanto as the head of Sales and Marketing, where his team successfully launched the company’s first ever biotech product Bt-Cotton.

Earlier, during his tenure with Hindustan Unilever for about 10 years, Manchanda received in-depth exposure in consumer product sales, distribution and marketing. He cherishes the memory of how at Unilever, as the Senior Brand Manager - Innovation, he had led the designing and launching of a tea-based beverage at HLL, which won Unilever's Global Innovation Award. Manchanda considers that award special among the several awards he had received at Unilever.

An MBA from the Indian Institute of Management, Ahmedabad; Manchanda is also a Doctor in Veterinary Sciences from HAU, Hisar.

Shrenik is a commerce graduate from Sydenham College, Mumbai and a Chartered Accountant from Institute of Chartered Accountants of India. Thereafter, Shrenik completed his post-graduation in business management from IIM Bangalore. He is also a Certified Investment Manager from the Securities and Investment Institute, UK.

He joined Brand Capital from Enam Securities where he was Executive Director – Investment Banking. He also set up the first international office for Enam in the UK.

Shrenik has over 16 years of experience in the areas of financial audit, management consulting, as well as Investment banking and has worked for companies like Lodha& Co., Accenture and A.T.

Sanjay Arte joined IVFA in 2001 and is based in Mumbai.

Sanjay is a Business Management Partner and was instrumental in translating IVFA’s business philosophy of ‘Building Businesses’ into practical, on-the-ground reality. He is closely involved in supporting and building IVFA companies in healthcare, media & entertainment, outsourced services, infrastructure services and precision engineering sectors.  

Sanjay joined IVFA with over 17 years of experience in marketing, operations and general management. He was the President of Swiss kitchen-systems manufacturer Franke’s Indian subsidiary and Managing Director of Sekurit Saint-Gobain in India. His work experience also includes assignments with Johnson & Johnson and Grindwell Norton.

Sanjay holds a Bachelor’s degree in Mechanical Engineering from the Indian Institute of Technology, Kanpur and a Master’s degree in Management from the University of Mumbai.

Shravan Talwar, 42 years, is a co-promoter of the Moolchand Group and a trustee of The Moolchand Trust.  He has served as the Chief Executive Officer of Moolchand Healthcare since 2004 and has played a pivotal role in its transformation.

Shravan is viewed to be a leader in the healthcare services space in India.  He has developed deep expertise in hospital design and development, rebranding and marketing new service development, physician change management and procurement.

He is also an active member of Young Presidents Organization (YPO), Delhi Chapter.

Prior to assuming his current role in 2004, Shravan was associated with McKinsey and Company in Europe, US and India for 6+ years as a part of its healthcare practice and focused on operations excellence, strategy and corporate finance engagements.

Shravan earned his MBA with distinction from Kellogg Business School of Northwestern University and graduated magna cum laude with a BA in Computational and Applied Math and Economics from Rice University.  At Rice he was elected to Phi Beta Kappa.

Siddharth Dhondiyal joined IVFA in 2006 and is based in Bengaluru.

As a Director – Fund Management, Siddharth looks at the Healthcare and Education sectors amongst other sectors for investments within IVFA and has been instrumental in developing the firms’ viewpoint and investment thesis in these sectors.

Siddharth had a six year stint with Accenture in its strategy consulting practice. During this period he consulted with companies in the pharmaceutical, consumer goods, industrial products and telecom industries.

Siddharth holds a Bachelor’s degree in Mechanical Engineering from the Indian Institute of Technology, Kanpur, Post Graduate Diploma in Management from the Indian Institute of Management, Kolkata and a Masters’ degree in Business Administration from INSEAD, France.

Dr. Chhatwal graduated with an undergraduate medical degree from Jawaharlal Nehru Medical College. He trained at Department of Surgery at the National University of Singapore and obtained a Doctoral degree (Ph.D.). Dr. Chhatwal studied international business (MBA) at a premier French engineering school, Ecole Nationale des ponts et Chaussees. He went on to study at the Fletcher School of Law and Diplomacy, Boston.

Dr. Chhatwal joined Advent India PE Advisors Pvt.Ltd. as an Industry Advisor in January 2011. Dr. Chhatwal is currently on the Board of the MediAssist Group of Companies.  Prior to this he was the CEO of Reliance Health, a Reliance ADA Group Company. ‘Reliance Health’ had interests across hospitals, health insurance administration (TPA), disease management and health care IT.  He was the project leader and built the largest privately-funded hospital, Kokilaben Dhirubhai Ambani Hospital. He was part of the founding team, as Chief Executive, of the largest Indian healthcare BPO and IT companies, Apollo Health Street Limited, and had a concurrent position as the CIO for the Apollo Hospitals Group.

Dr. Chhatwal is the Co-Chairman of the Entrepreneurship Committee at the Indian Merchants’ Chamber (IMC) and was on the Board of Governors of ICFAI Business Schools. His work as principal investigator helped define the ‘Healthcare IT and Infrastructure Standards’ for the Government of India.

Shriram started DaVita NephroLife in 2009 with the vision of providing India's highest quality dialysis and holistic nephrology services. His mission is to improve the quality and longevity of life for all patients at DaVita NephroLife. He has devised unique clinical formats with technology enabled care to change the paradigm in nephrology service delivery.

Today, DaVita NephroLife is present across six locations in Bangalore with a further fifteen centres in the pipeline across India in the next six months. DaVita NephroLife is poised to be India's largest chain of standalone dialysis and kidney care centres. He recently closed a successful second round of funding with renowned VC major New Enterprise Associates and DaVita Inc. - the second largest kidney care provider worldwide.

Shriram began his career at Mars and Co., a boutique consulting firm based out of New York. During his time there, he advised Fortune 500 Companies in FMCG, Automotive and Health Insurance verticals in the United States, China, Hong Kong and India. He then returned to India as CEO of the renowned NU Hospitals, a 75 bed nephro-uro speciality hospital. He is also an Advisory Board Member of InstaHealth Solutions, a Healthcare Information Systems Company. Shriram holds an double major from Carnegie Mellon University in Economics and Information Systems.

Viren Shetty is the Senior Vice President of Strategy and Planning at Narayana Hrudayalaya Group of Hospitals and also sits on the Board of Directors. He started his career in the hospital engineering division and executed 8 projects as part of NH’s expansion strategy. He is currently working on streamlining the operating procedures for various group hospitals in order to maintain Narayana Hrudayalaya’s goal of delivering the highest quality care at the most affordable price.

Viren has a Bachelor’s in Engineering from the RV College of Engineering and an MBA from the Stanford Graduate School of Business.

Shyam Powar is Business Head, Corporate Finance, Allegro Corporate Finance Advisors Private Limited
• 21 years + experience in multinational organizations including as Director (Corporate Finance)Andersen and Larsen & Toubro
• Expertise in M&A, Debt Restructuring and Take-outs, Private Equity and IPO advisory
• MBA from Tulane University (US) and Chemical Engineer – IT BHU

Rajat Goel, is Co-founder and CEO of Eye-Q hospitals. He has 16 years of corporate experience in companies like Godrej and Bausch & Lomb including 3 years as Head of surgical business for Bausch & Lomb for SAARC countries.Rajat is an MBA from IIM Ahmedabad.

Eye-Q Super-specialty Eye Hospitals is a leading eye care chain in North India. Eye-Q hospitals are committed to providing the best quality standardized eye care at truly affordable costs right across the country. They are an ISO 9001-2000 registered organization.

Presently Eye-Q have hospitals in Gurgaon, Rewari, Haldwani, New Railway Road, Gurgaon, Rohtak, Rudrapur, Saharanpur, Muzaffarnagar, Yamunanagar, Hisar, Roorkee, Fatehabad, Surat, Lucknow, thus making the best of eye care available to a substantial segment of the population. Eye-Q is the dynamic new code in super-specialty eye care. It covers everything, from maintaining optimum vision, preventing deterioration to correcting vision related problems. All this through thier exceptional array of preventive and corrective procedures and cutting-edge practices.

Dr. Praneet Kumar is the CEO of Radiant Life Care Private Limited. Radiant is in the business of developing, redeveloping, operating and managing hospitals. Radiant is currently managing the 700 bed BLK Super Specialty Hospital in Delhi. The Company is set to commission close to 1500 beds over the next 2 years spread over Delhi and other Tier I towns. Besides these, Radiant has also taken up management of two 250-bed specialty hospitals in Tier II towns.

Dr Praneet is a senior healthcare professional, with over 34 years of experience including 25 years as a healthcare business manager. He is a Visionary, Strategist, Tactician, Leader, Orator, Mentor and Business Manager specializing in Strategy Formulation, Planning, Startup, Operations, Re-engineering, Turn Around and Organization Development.

He started his career with Moolchand Hospital, New Delhi and evolved into a hospital management consultant. During his 16 years at Fortis Healthcare, he oversaw the functions of Medical Services, Projects, Strategic Planning, Quality Assurance and Public Private Partnerships.

He represents various committees including Member Healthcare and Health Insurance Forum of FICCI.Hehas now taken over as the Chairman of the Appeals / Complaints Redressal Committee of NABH. He is also on the Boards of QCI and NABH.

He is the recipient of the 1999 Yoshioka / Japan Hospital Fellowship of International Hospital Federation and was enlisted as an outstanding achiever in healthcare in ‘Pride of Rajasthan’.

Niten Malhan is a Managing Director with Warburg Pincus.  He has been with Warburg Pincus since 2001, is co-head of the firm's Mumbai office and focuses on the firm’s investment activities in India. Previously, he worked as an engagement manager with McKinsey & Company in New Delhi, Jakarta and Boston and was a director of business development for a Silicon Valley start-up. Mr. Malhan is a director of ACB (India), Alliance Tire, Diligent Power, Havells India, Lemon Tree Hotels, Metropolis Healthcare and Punj Lloyd. He also serves on the board of the Indian Private Equity and Venture Capital Association (IVCA) and co-chairs the Private Equity sub-group of the Capital Markets Committee for the Federation of Indian Chambers of Commerce and Industry (FICCI). Mr. Malhan holds a B.S. in computer science and engineering from IIT-Delhi, and an M.B.A. from the Indian Institute of Management, Ahmedabad.